NPPB and hydrops fetalis: Although clinical studies have varied in the design and objectives regarding the use of natriuretic peptides in different categories of HF patients, the use of BNP/NT-proBNP for guiding pharmacological treatment in HF has been associated with reduced mortality and fewer hospitalizations, particularly in patients under 75 years of age with HFrEF [72].